Showing results (991-1000 of 2,471) with videos related to

Sort By:
Pageof 248
ACS Infectious Diseases|May 19, 2018
Magnetic Glycol Chitin-Based Hydrogel Nanocomposite for Combined Thermal and d-Amino-Acid-Assisted Biofilm DisruptionEric C Abenojar, Sameera Wickramasinghe, Minseon Ju, et al.
ACS Infectious Diseases|May 1, 2018
Effects of the 1- N-(4-Amino-2 S-hydroxybutyryl) and 6'- N-(2-Hydroxyethyl) Substituents on Ribosomal Selectivity, Cochleotoxicity, and Antibacterial Activity in the Sisomicin Class of Aminoglycoside AntibioticsAmr Sonousi, Vikram A Sarpe, Margarita Brilkova, et al.
ACS Infectious Diseases|May 1, 2018
Compartment-Specific Labeling of Bacterial Periplasmic Proteins by Peroxidase-Mediated BiotinylationUday S Ganapathy, Lu Bai, Linpeng Wei, et al.
ACS Infectious Diseases|April 13, 2019
Label-Free Proteomic Analysis Reveals Parasite-Specific Protein Alterations in Macrophages Following Leishmania amazonensis, Leishmania major, or Leishmania infantum InfectionFernanda Negrão, Carolina Fernandez-Costa, Nahiara Zorgi, et al.
ACS Infectious Diseases|August 25, 2018
Noninvasive Urine Biomarker Lateral Flow Immunoassay for Monitoring Active OnchocerciasisRyan J Shirey, Daniel Globisch, Lisa M Eubanks, et al.
ACS Infectious Diseases|August 25, 2018
Pharmacokinetics of β-Lactam Antibiotics: Clues from the Past To Help Discover Long-Acting Oral Drugs in the FuturePaul W Smith, Fabio Zuccotto, Robert H Bates, et al.
ACS Infectious Diseases|June 12, 2019
Dual-Pharmacophore Pyrithione-Containing Cephalosporins Kill Both Replicating and Nonreplicating Mycobacterium tuberculosisLandys Lopez Quezada, Kelin Li, Stacey L McDonald, et al.
ACS Infectious Diseases|August 4, 2021
The CARB-X Portfolio of Nontraditional Antibacterial ProductsErin M Duffy, Ed T Buurman, Su L Chiang, et al.
ACS Infectious Diseases|November 15, 2022
A Frog-Derived Cathelicidin Peptide with Dual Antimicrobial and Immunomodulatory Activities Effectively Ameliorates Staphylococcus aureus-Induced Peritonitis in MiceJie Shi, Jing Wu, Qian Chen, et al.
ACS Infectious Diseases|February 21, 2023
Pyrido-Dibemequine Metabolites Exhibit Improved Druglike Features, Inhibit Hemozoin Formation in Plasmodium falciparum, and Synergize with Clinical AntimalarialsJohn Okombo, Malkeet Kumar, Devasha Redhi, et al.
Pageof 248